Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and pathological cardiac remodeling. This study aims to analyze the relationship between the frequency and severity of ventricular arrhythmias and the extent of pathological cardiac remodeling in patients with PPCM, highlighting the clinical implications for disease management and prognosis. Materials and methods. A total of 104 patients with PPCM, treated at the Republican Specialized Scientific and Practical Medical Center of Cardiology from 1997 to 2022, were included in this study. Patients were categorized into two groups based on their left ventricular ejection fraction (LVEF): group I (LVEF <35%) and group II (LVEF 36-45%). Diagnostic criteria followed the European Society of Cardiology guidelines for PPCM. All patients underwent electrocardiography (ECG), echocardiography, 24-hour Holter monitoring, and clinical assessments to evaluate cardiac function and arrhythmias. Statistical analysis was performed using descriptive and inferential methods. Results. The average age of patients was 30.15±2.9 years. Most cases (76%) were diagnosed in the postpartum period, with 49% detected within three months after delivery. Ventricular arrhythmias, particularly high-grade arrhythmias (Lown classes III, IVA, IVB), were significantly more frequent in group I. Severe pathological remodeling of the heart, including increased left ventricular end-diastolic and end-systolic dimensions, was 10% more prevalent in group I compared to group II. Additionally, hypotension and severe sinus tachycardia were more commonly observed in group I patients, further indicating the association between advanced cardiac dysfunction and arrhythmias. Conclusion. The findings suggest a strong association between ventricular arrhythmias and pathological cardiac remodeling in PPCM patients, particularly those with LVEF <35%. These results underscore the importance of early identification and tailored therapeutic strategies to manage arrhythmias and prevent adverse outcomes in this vulnerable population.
| Mualliflar | Xudoyberganov , Otabek, Tsoi , Igor, Abdullaev , Timur, Mirzarakhimova , Saodat, Khudoyberganov, Otabek, Tsoi, I, Abdullaev , T, Mirzarakhimova , S, Худойберганов, Отабек, Цой, Игорь, Абдуллаев, Тимур, Мирзарахимова, Саодат |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-03-30 |
| Jild | 1 |
| Son | 1 |
| Betlar | 51-58 |
| Til | O‘zbek |
| DOI | 10.70626/cardiouz-2024-1-00007 |
DOI: 10.70626/cardiouz-2024-1-00007 · Maqolaning asl sahifasi
peripartum cardiomyopathy, ventricular arrhythmias, cardiac remodeling, LVEF, postpartum period, перипартальная кардиомиопатия, желудочковые аритмии, ремоделирование сердца, ФВЛЖ, послеродовой период, peripartal kardiomiopatiya, qorinchalar aritmiyalari, yurak remodellanishi, ChQOF, tug‘ruqdan keyingi davr
The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic…
Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased…
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations…
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…
Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors…
Background. Atherosclerosis is a leading cause of cardiovascular mortality worldwide, significantly impacting public health. microRNA, as key regulators of gene expression, play a crucial role in the pathogenesis of…
Background. To study the characteristics of the clinical course of arterial hypertension by gender in the population of the Aral Sea region and to strengthen effective preventive measures. Materials and methods. The…
Background. This study explores the impact of anxiety and depressive disorders on the rehabilitation outcomes and long-term prognosis of patients with acute myocardial infarction (AMI) and unstable angina. The aim is to…
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Coronary artery disease (CAD) accounts for one third of all deaths from the diseases of the…
Background. The 2023 ESC guidelines on cardiomyopathies introduce significant updates in diagnostic criteria, terminology, and treatment protocols. These guidelines aim to provide comprehensive approaches for diagnosis…